Definition: The metabolism of a drug in the liver (and sometimes gut wall) immediately after absorption from the gastrointestinal tract, resulting in reduced bioavailability
It has a negligible effect on cortisol and prolactin levels
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: a meta-analysis of seven long-term studies
With prolonged use, the pituitary's natural GH output decreases a phenomenon documented in endocrinology literature
Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al
[17] Palatin ceased development of melanotan-II in 2000, and synthesized, patented, and began to develop bremelanotide, a likely metabolite of melanotan-II that differs from melanotan-II in that it has a hydroxyl group where melanotan-II has an amide